IFF Partners With Kemira on DEB Technology — Could This Mega-Project Reinvent Its Health & Biosciences Future?

International Flavors & Fragrances Inc. (IFF) presented its third-quarter results for 2025, showcasing a steady operational performance amidst challenging market conditions. The company maintained flat sales compared to the previous year, despite headwinds such as geopolitical challenges, macroeconomic uncertainty, and soft demand in certain sectors. Growth was observed in the Scent and Taste segments, counterbalancing weakness in Food Ingredients and Health & Biosciences, particularly in North America. The company’s adjusted operating EBITDA grew by 7%, with an improvement of 130 basis points in margin, reflecting efficient cost management and productivity initiatives. This financial discipline allowed IFF to align its performance with the guidance set earlier in the year. The firm continues to reinvest in innovation and business development while focusing on profitability, positioning itself for sustainable growth.